ARKG vs. ARKK

In the year-to-date period, ARKG achieves a -7.41% return, which is significantly lower than ARKK's 2.82% return. Over the past 10 years, ARKG has underperformed ARKK with an annualized return of 0.19%, while ARKK has yielded a comparatively higher 11.72% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Both ARKG and ARKK have an expense ratio of 0.75%.

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ARKG Sharpe Ratio is -0.38, which is lower than the ARKK Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of ARKG and ARKK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ARKG nor ARKK has paid dividends to shareholders.

The maximum ARKG drawdown since its inception was -83.59%, roughly equal to the maximum ARKK drawdown of -80.91%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKK. For additional features, visit the drawdowns tool.

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 14.24% compared to ARK Innovation ETF (ARKK) at 12.02%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.